Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance

Documenti analoghi

• Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases
  di: Daisuke Matsumoto, et al.
  Pubblicazione: (2024)
• Exploring experimental models of prostate cancer in chemoprevention: Oxidative stress as a key pathway to translational research
  di: Aya Naiki‐Ito, et al.
  Pubblicazione: (2025)
• Dose modification in enzalutamide and abiraterone plus prednisolone for castration‐resistant prostate cancer: A subanalysis from the ENABLE study for PCa
  di: Nobumichi Tanaka, et al.
  Pubblicazione: (2024)
• Efficacy of prostatectomy using a Retzius‐sparing approach as an additional excision in anal canal carcinoma after brachytherapy for prostate adenocarcinoma
  di: Takahiro Yanase, et al.
  Pubblicazione: (2025)
• Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
  di: Toshifumi Takahashi, et al.
  Pubblicazione: (2024)